氨基葡萄糖使用、炎症与遗传易感性及2型糖尿病发病率:英国生物银行前瞻性研究
该研究分析英国生物银行404,508名基线无糖尿病、癌症或心血管疾病且完成补充剂使用问卷的参与者,中位随访8.1年记录7,228例新发2型糖尿病。调整年龄、性别、BMI、种族、中心、Townsend剥夺指数、生活方式因素、疾病史及其他补充剂使用后,氨基葡萄糖使用与2型糖尿病风险显著降低相关(HR 0.83,95%CI 0.78-0.89)。该负相关在基线C反应蛋白较高者中更明显(P-interaction=0.02),而2型糖尿病遗传风险评分未改变该关联(P-interaction=0.99)。
要点
- 氨基葡萄糖使用与2型糖尿病风险显著降低相关(HR 0.83,95%CI 0.78-0.89)。
- 该负相关在基线C反应蛋白较高者中更明显(P-interaction=0.02)。
- 2型糖尿病遗传风险评分未改变该关联(P-interaction=0.99)。
核心结论
- 氨基葡萄糖使用与2型糖尿病发病风险降低相关。
研究设计与样本
- 前瞻性分析英国生物银行404,508名基线无糖尿病、癌症或心血管疾病且完成补充剂使用问卷的参与者。
- 采用Cox比例风险模型评估习惯性氨基葡萄糖使用与新发2型糖尿病风险的关联。
主要发现
- 中位随访8.1年期间记录7,228例新发2型糖尿病。
- 调整年龄、性别、BMI、种族、中心、Townsend剥夺指数、生活方式因素、疾病史及其他补充剂使用后,氨基葡萄糖使用与2型糖尿病风险显著降低相关(HR 0.83,95%CI 0.78-0.89)。
- 该负相关在基线C反应蛋白较高者中比在较低者中更明显(P-interaction=0.02)。
- 2型糖尿病遗传风险评分未改变该关联(P-interaction=0.99)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Glucosamine is a widely used supplement typically taken for osteoarthritis and joint pain. Emerging evidence suggests potential links of glucosamine with glucose metabolism, inflammation, and cardiometabolic risk. We prospectively analyzed the association of habitual glucosamine use with risk of type 2 diabetes (T2D) and assessed whether genetic susceptibility and inflammation status might modify the association. RESEARCH DESIGN AND METHODS: This study analyzed 404,508 participants from the UK Biobank who were free of diabetes, cancer, or cardiovascular disease at baseline and completed the questionnaire on supplement use. Cox proportional hazards models were used to evaluate the association between habitual use of glucosamine and risk of incident T2D. RESULTS: During a median of 8.1 years of follow-up, 7,228 incident cases of T2D were documented. Glucosamine use was associated with a significantly lower risk of T2D (hazard ratio 0.83, 95% CI 0.78-0.89) after adjustment for age, sex, BMI, race, center, Townsend deprivation index, lifestyle factors, history of disease, and other supplement use. This inverse association was more pronounced in participants with a higher blood level of baseline C-reactive protein than in those with a lower level of this inflammation marker (P-interaction = 0.02). A genetic risk score for T2D did not modify this association (P-interaction = 0.99). CONCLUSIONS: Our findings indicate that glucosamine use is associated with a lower risk of incident T2D.
引用
- Ma H, Li X, Zhou T, et al. Glucosamine Use, Inflammation, and Genetic Susceptibility, and Incidence of Type 2 Diabetes: A Prospective Study in UK Biobank. Diabetes Care. 2020. PMID: 31988063. doi:10.2337/dc19-1836
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。